CLINICAL SIGNIFICANSE OF PROSTATE-SPECIFIC ANTIGEN IN BREAST CANCER PATIENTS

by N. S. Sergeeva, T. A. Karmakova, I. I. Alentov, A. D. Zikiryahodzhaev, D. R. Ortabaeva, A. D. Kaprin
Published 2020-12-01

KIM-1 (kidney injury molecule 1) in the urine of renal cell carcinoma patients

by K. Yu. Kanukoev, N. S. Sergeeva, T. A. Karmakova, N. V. Marshutina, M. P. Solokhina, K. M. Nyushko, B. Ya. Alekseev, A. D. Kaprin
Published 2020-11-01

Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile

by Anne V. Yagolovich, Artem A. Artykov, Tatiana A. Karmakova, Maria S. Vorontsova, Andrey A. Pankratov, Alexander A. Andreev-Andrievsky, Dmitry A. Dolgikh, Mikhail P. Kirpichnikov, Marine E. Gasparian
Published 2020-04-01

Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression

by Andrey A. Rosenkranz, Andrey A. Rosenkranz, Tatiana A. Slastnikova, Tatiana A. Karmakova, Maria S. Vorontsova, Natalia B. Morozova, Vasiliy M. Petriev, Vasiliy M. Petriev, Alexey S. Abrosimov, Yuri V. Khramtsov, Tatiana N. Lupanova, Alexey V. Ulasov, Raisa I. Yakubovskaya, Georgii P. Georgiev, Alexander S. Sobolev, Alexander S. Sobolev
Published 2018-11-01